Crinetics Pharmaceuticals CRNX Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:DeferredCompensationPlanAssets.
The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Crinetics Pharmaceuticals's other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Crinetics Pharmaceuticals's other non-current assets?
- Crinetics Pharmaceuticals (CRNX) reported other non-current assets of $4.9M in Q1 2026.
- How has Crinetics Pharmaceuticals's other non-current assets changed year-over-year?
- Crinetics Pharmaceuticals's other non-current assets decreased by 65.4% year-over-year, from $14.15M to $4.9M.
- What is the long-term trend for Crinetics Pharmaceuticals's other non-current assets?
- Over 5 years (2020 to 2025), Crinetics Pharmaceuticals's other non-current assets has grown at a 141.0% compound annual growth rate (CAGR), from $40K to $3.25M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.